Search for: "Smithkline Beecham Corporation" Results 21 - 40 of 83
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
An antitrust class action lawsuit against Valeant Pharmaceuticals Inc. and SmithKline Beecham Corp., doing business as GlaxoSmithKline and GlaxoSmithKline plc (jointly “GSK”) claimed that these corporations, the ones responsible for the production and marketing of Wellbutrin XL, worked to limit the availability of generic versions of Wellbutrin XL, far less expensive alternatives to the brand-name medication. [read post]
6 Aug 2017, 3:37 pm by Lawrence B. Ebert
" n100n97 Canal Barge, slip op. at *1; Calzaturficio, 201 F.R.D. at 37; Smithkline Beecham Corp., slip op. at *9; Taylor, 166 F.R.D. at 361.n98 Canal Barge, slip op. at *1; Smithkline Beecham Corp., slip op. at *9; Taylor, 166 F.R.D. at 361.n99 Canal Barge, slip op. at *2.n100 Rainey, 26 F. [read post]
9 Oct 2009, 11:50 am
In his remarks before thousands of employees on the USPTO campus, Secretary Locke said "David is taking on a big job… Promoting and protecting U.S. [...]...USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007… [read post]
19 Oct 2009, 5:53 pm
  It is impossible not to recognize the new [...]...USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline… [read post]
13 Nov 2009, 11:52 am
USPTO Agrees to Withdraw Claims & Continuations Rules PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. [read post]
11 Oct 2007, 2:32 pm
According to the fifty-two page, eight-count complaint signed by Sherry Knowles, Global Head of Corporate Intellectual Property for SmithKline Beecham,3. [read post]
3 Nov 2012, 8:44 am by David Freedman
SmithKline Beecham Corporation, the Supreme Court addressed the issue of the “outside sales exemption” to the Fair Labor Standards Act (“FLSA”), the Federal law that requires employers to pay an overtime wage premium when employees work more than 40 hours in a week. [read post]
10 May 2010, 5:33 am by Bexis
  Sadly, as the last part of that Kirchner cite reveals, the section 1447(d) issue in that case ultimately went the plaintiffs' way.The latest case of remand fever is Aaron v Smithkline Beecham Corp., 2010 WL 1752546 (S.D. [read post]
12 Jul 2010, 11:34 pm
The New York Times reports that, as early as the fall of 1999, SmithKline Beecham, maker of a popular diabetes medicine called "Avandia", found out, through studies it conducted, that the drug posed significantly greater cardiac risks than other leading diabetes medicines. [read post]
29 Mar 2011, 12:33 pm by Bexis
SmithKline Beecham Corp., 2010 WL 3119926, at *4 (E.D. [read post]
25 Feb 2010, 6:34 am by Brian Wolfman
Smithkline Beecham Corporation, the Seventh Circuit rejected this argument in a case brought by a twenty-three-year-old woman who committed suicide two days after she started taking Paxil, a popular SSRI. [read post]
17 Feb 2011, 1:59 pm by AALRR
  SmithKline Beecham Corporation (“Glaxo”) hired plaintiffs in 2003 to meet with physicians and encourage them to prescribe Glaxo pharmaceuticals. [read post]
24 Dec 2015, 4:00 am by Administrator
Finally, in 2004, I found my current home as a corporate law professor. [read post]
1 Apr 2008, 7:38 am
Patent and Trademark Office (PTO) from putting its new claims and continuation rules into effect (SmithKline Beecham Corporation et al. v. [read post]